Armstrong A, Agada N, Xu W, Gallo G. An Update on the Long-Term Safety Experience of Ixekizumab: Results from the Psoriasis Clinical Development Program with More than 3 Years of Follow-up from 12 Clinical Trials and More Than 15000 Patient-Years of Exposure to Ixekizumab. J of Skin [Internet]. 2018Dec.17 [cited 2024Sep.20];2:S116. Available from: https://dermsquared.com/skin/article/view/498